The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease

QR Code

The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease

None

Saved in:

Bibliographic Details
Main Authors:	Hernández-Echeagaray, Elizabeth, Rosa-López, Gabriela De la, Mendoza-Duarte, Ernesto
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/28339
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
by: Cunha-Oliveira, Teresa, et al.
Published: (2012)

Cellular Therapies for Huntington’s Disease
by: Kelly, C. M., et al.
Published: (2012)

Early Dysfunction of Neural Transmission and Cognitive Processing in Huntington’s Disease
by: Sandstrom, Michael I., et al.
Published: (2012)

Unraveling Reduction Mechanisms from Np(Ⅵ) to Np(Ⅴ) by Acetaldoxime
by: LI Xiaobo1, 2, ZHANG Meng1, , WU Qunyan2, , SHI Weiqun2,
Published: (2025-01-01)

Biomarkers for Huntington’s Disease
by: Kobal, Jan, et al.
Published: (2012)

Cognition in Huntington's Disease
by: Wahlin, Tarja-Brita Robins, et al.
Published: (2012)

Endogenous Attention in Normal Elderly, Presymptomatic Huntington’s Disease and Huntington’s Disease Subjects
by: Peretti, Charles-Siegfried, et al.
Published: (2012)

Applications of Nano Penta (N_P) Separation axioms using N_P_ open sets
by: Rana B.Yaseen, et al.
Published: (2022-11-01)

Energy Metabolism in Huntington’s Disease
by: Ribeiro, Fabíola M., et al.
Published: (2012)

Cholesterol Metabolism in Huntington’s Disease
by: Leoni, Valerio, et al.
Published: (2012)

From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington’s Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq<sup>®</sup>)
by: João Rafael Dias Pinto, et al.
Published: (2025-06-01)

Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma
by: Kazumi Eckenstein, et al.
Published: (2025-06-01)

Prospects of etiopathogenetic treatment of Huntington’s disease
by: O. B. Kondakova, et al.
Published: (2023-03-01)

Gene Silencing Therapies for Huntington’s Disease
by: Chunlan Hao, et al.
Published: (2025-05-01)

Actualización en enfermedad de Huntington
by: Jorge Michel Rodríguez Pupo, et al.
Published: (2014-01-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Assessment of ovarian dysfunction induced by environmental toxins: a systematic review
by: Lu An, et al.
Published: (2025-07-01)

Retinal and choroidal morphological changes in Huntington's disease
by: S. N. Svetozarskiy, et al.
Published: (2019-03-01)

Modeling Huntington’s Disease: in vivo, in vitro, in silico
by: Tunalı, Nagehan Ersoy
Published: (2012)

Alterations in Expression and Function of Phosphodiesterases in Huntington’s Disease
by: Laprairie, Robert, et al.
Published: (2012)

Computational Investigations of Cognitive Impairment in Huntington's Disease
by: Davelaar, Eddy J.
Published: (2012)

BDNF in Huntington’s Disease: Role in Pathogenesis and Treatment
by: Baydyuk, Maryna, et al.
Published: (2012)

A special machine for solving NP-complete problems
by: Jin Xu, et al.
Published: (2025-07-01)

Discovering and Uncovering
by: Barry Chametzky
Published: (2022-06-01)

Role of mitochondrial and lysosomal dysfunction in acute pancreatitis pathogenesis
by: Yuliya V Yevsyutina, et al.
Published: (2016-08-01)

MITOCHONDRIAL DYSFUNCTION AS POSSIBLE CAUSE OF IMPAIRED FOLLICULAR DEVELOPMENT
by: A. A. Pozdnyakova, et al.
Published: (2016-06-01)

Evaluation of Mitochondrial Functions and Dysfunctions in Muscle Biopsy Samples
by: Capel, Frédéric, et al.
Published: (2012)

Role of Mitochondrial Dysfunction in Motor Neuron Degeneration in ALS
by: Santa-Cruz, Luz Diana, et al.
Published: (2012)

The Role of Oxidative Stress and Mitochondrial Dysfunction in the Pathogenesis of Fibromyalgia
by: Cordero, Mario D., et al.
Published: (2012)

Multi-omics study of mitochondrial dysfunction in the pathogenesis of hyperuricemia
by: Yuechang Hong, et al.
Published: (2025-12-01)

Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases
by: Federica Davì, et al.
Published: (2025-06-01)

Huntington’s disease modeling on HEK293 cell line
by: D. V. Sharipova, et al.
Published: (2017-12-01)

Molecular Mechanism of Huntington’s Disease — A Computational Perspective
by: Rossetti, Giulia, et al.
Published: (2012)

Ameliorating Huntington's Disease by Targeting Huntingtin mRNA
by: Evers, Melvin M., et al.
Published: (2012)

Differential response of neurons to autophagy modulation in Huntington’s disease
by: Ankit Sharma, et al.
Published: (2025-12-01)

PLK3 facilitates replication of swine influenza virus by phosphorylating viral NP protein
by: Caiyue Ren, et al.
Published: (2023-12-01)

Impact of AgNP on the Inhibition of Fecal Coliforms by 3DP-Modified Chitosan Membranes
by: Anthony C. Ogazi, et al.
Published: (2024-11-01)

NP-completeness of the Eulerian walk problem for a multiple graph
by: Alexander V. Smirnov
Published: (2024-03-01)

The Role of EZH2 in Initiating Epigenetic Regulation of CRSwNP
by: Zeng R, et al.
Published: (2025-07-01)

Complex interplay between gene deletions and the environment uncovers cellular roles for genes of unknown function in Escherichia coli
by: Kaat Sondervorst, et al.
Published: (2025-07-01)